HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hsu-Feng Lu Selected Research

danthron

5/2011Danthron inhibits murine WEHI-3 cells in vivo, and enhances macrophage phagocytosis and natural killer cell cytotoxic activity in leukemic mice.
7/2010Danthron induces DNA damage and inhibits DNA repair gene expressions in GBM 8401 human brain glioblastoma multiforms cells.
3/2010Danthron induced apoptosis through mitochondria- and caspase-3-dependent pathways in human brain glioblastoma multiforms GBM 8401 cells.
11/2009Danthron inhibits the migration and invasion of human brain glioblastoma multiforme cells through the inhibition of mRNA expression of focal adhesion kinase, Rho kinases-1 and metalloproteinase-9.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hsu-Feng Lu Research Topics

Disease

64Neoplasms (Cancer)
10/2022 - 05/2005
26Leukemia
11/2021 - 01/2005
14Lung Neoplasms (Lung Cancer)
12/2016 - 05/2004
10Body Weight (Weight, Body)
09/2020 - 02/2010
10Breast Neoplasms (Breast Cancer)
10/2016 - 01/2004
9Melanoma (Melanoma, Malignant)
03/2020 - 02/2013
9Neoplasm Metastasis (Metastasis)
11/2017 - 03/2008
7Osteosarcoma (Osteogenic Sarcoma)
03/2020 - 11/2010
6Glioblastoma (Glioblastoma Multiforme)
10/2022 - 11/2009
6Uterine Cervical Neoplasms (Cancer of the Cervix)
10/2016 - 11/2007
6Ataxia Telangiectasia (Louis Bar Syndrome)
10/2016 - 07/2010
5Mouth Neoplasms (Oral Cancer)
09/2020 - 09/2007
5Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2017 - 09/2007
4Insulin Resistance
03/2021 - 12/2005
4Colonic Neoplasms (Colon Cancer)
08/2017 - 12/2010
4Hepatocellular Carcinoma (Hepatoma)
07/2015 - 11/2013
4Ganglion Cysts (Ganglion)
03/2010 - 03/2009
3Infections
01/2022 - 01/2018
3Obesity
12/2020 - 12/2005
3Stomach Neoplasms (Stomach Cancer)
11/2018 - 05/2005
3Liver Neoplasms (Liver Cancer)
01/2015 - 07/2010
3Necrosis
05/2014 - 01/2006
2Fatty Liver
03/2021 - 01/2020
2Non-alcoholic Fatty Liver Disease
03/2020 - 01/2020
2Prostatic Neoplasms (Prostate Cancer)
12/2019 - 04/2014
2Type 2 Diabetes Mellitus (MODY)
01/2018 - 12/2005
2B-Cell Lymphoma (Lymphoma, B Cell)
11/2017 - 11/2009
2Fatigue
09/2017 - 03/2015
2Skin Neoplasms (Skin Cancer)
03/2017 - 02/2013
2Carcinogenesis
01/2015 - 01/2005

Drug/Important Bio-Agent (IBA)

13Proteins (Proteins, Gene)FDA Link
11/2018 - 03/2008
12CaspasesIBA
12/2019 - 11/2009
10CurcuminIBA
04/2021 - 11/2006
9Biological ProductsIBA
10/2022 - 03/2010
8Reactive Oxygen Species (Oxygen Radicals)IBA
12/2016 - 03/2008
7Caspase 3 (Caspase-3)IBA
11/2017 - 05/2006
7DNA (Deoxyribonucleic Acid)IBA
10/2016 - 01/2004
6casticinIBA
09/2020 - 03/2016
5Cantharidin (Cantharides)IBA
03/2017 - 07/2014
5MethyltransferasesIBA
10/2016 - 07/2010
5Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
09/2015 - 07/2010
5Matrix Metalloproteinases (MMPs)IBA
01/2015 - 11/2006
4Pharmaceutical PreparationsIBA
09/2020 - 11/2009
4Ouabain (G Strophanthin)IBA
12/2019 - 11/2017
4QuercetinIBA
11/2018 - 08/2009
4Matrix Metalloproteinase 2 (Gelatinase A)IBA
03/2016 - 09/2013
4NF-kappa B (NF-kB)IBA
01/2015 - 05/2005
4AnthraquinonesIBA
05/2014 - 11/2009
4Messenger RNA (mRNA)IBA
02/2013 - 11/2009
4danthronIBA
05/2011 - 11/2009
42-aminofluoreneIBA
01/2005 - 01/2004
4N-acetyltalosaminuronic acid (NAT)IBA
01/2005 - 01/2004
3bisdemethoxycurcuminIBA
10/2022 - 12/2016
3demethoxycurcuminIBA
11/2021 - 03/2020
3Adenosine Triphosphatases (ATPase)IBA
12/2019 - 11/2017
3bufalinIBA
09/2018 - 01/2015
3Alanine Transaminase (SGPT)IBA
09/2018 - 09/2017
3Complementary DNA (cDNA)IBA
11/2017 - 07/2015
3ChitosanIBA
09/2017 - 11/2013
3Antineoplastic Agents (Antineoplastics)IBA
03/2017 - 08/2011
3isothiocyanic acidIBA
12/2016 - 08/2011
3benzyl isothiocyanateIBA
12/2016 - 08/2011
3Caspase 8 (Caspase-8)IBA
12/2016 - 12/2010
3Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
10/2016 - 08/2011
3diallyl trisulfideIBA
11/2015 - 05/2012
314-3-3 Proteins (14-3-3 Protein)IBA
09/2015 - 07/2010
3chrysophanic acidIBA
05/2014 - 07/2010
3diallyl disulfide (diallyl disulphide)IBA
09/2013 - 09/2008
3AcetyltransferasesIBA
01/2005 - 01/2004
2Insulin (Novolin)FDA Link
03/2021 - 12/2005
2Death Domain ReceptorsIBA
01/2021 - 09/2007
2PolyphenolsIBA
09/2020 - 08/2010
2Therapeutic UsesIBA
03/2020 - 01/2016
2Cardiac GlycosidesIBA
12/2019 - 05/2019
2monocyte-macrophage differentiation antigenIBA
09/2018 - 11/2015
2L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
09/2018 - 09/2017
2Aspartate Aminotransferases (Aspartate Transaminase)IBA
07/2018 - 09/2017
2laminaranIBA
07/2018 - 05/2018
2Apoptosis Inducing FactorIBA
11/2017 - 11/2009
2Cytochromes c (Cytochrome c)IBA
11/2017 - 11/2009
2Apoptosis Regulatory ProteinsIBA
11/2017 - 08/2011
2FlavonoidsIBA
11/2017 - 01/2015
2endonuclease GIBA
11/2017 - 11/2009
2AntioxidantsIBA
11/2017 - 07/2009
2sulforaphaneIBA
01/2017 - 05/2016
2alpha phellandreneIBA
11/2016 - 07/2014
2DAPIIBA
10/2016 - 05/2012
2ChromatinIBA
10/2016 - 04/2016
2Phosphotransferases (Kinase)IBA
10/2016 - 09/2015
2Estrogen ReceptorsIBA
01/2016 - 01/2004
2O(6)-Methylguanine-DNA MethyltransferaseIBA
01/2015 - 10/2010
2Phosphates (Orthophosphate)IBA
01/2015 - 11/2009
2kaempferolIBA
01/2015 - 11/2010
2phenethyl isothiocyanate (PEITC)IBA
09/2014 - 08/2011
2allyl sulfideIBA
09/2013 - 05/2012
2amsonic acid (DAS)IBA
09/2013 - 05/2012
2triptolideIBA
03/2013 - 02/2013

Therapy/Procedure

4Therapeutics
03/2020 - 04/2006
3Drug Therapy (Chemotherapy)
01/2020 - 04/2006
2Oral Administration
09/2013 - 07/2011